Nanoco strategy; Avanci Broadcast launch; new Genentech suit; royalty underpayments; litigation finance soaring; plus much more

Nanoco strategy; Avanci Broadcast launch; new Genentech suit; royalty underpayments; litigation finance soaring; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 06 March

Interview: Nanoco eyeing further assertions following big-money Samsung pay-out, says CEO. Read more here

Data dive: Five things to know about patent case trends in the Western District of Texas. Read more here

TUESDAY 07 March

Avanci launches new platform for ATSC 3.0 broadcasting standard. Read more here

Infamous Cabilly patents come back to haunt Biogen in new Genentech suit. Read more here

US commenters warn of ‘unintended consequences’ in pharma patent crackdown. Read more here

WEDNESDAY 08 March

Interview: Tackling gender inequality in Japan's IP profession. Read more here

Long read: A roadmap for industry-academia collaboration to advance IP policy. Read more here

Allegations of royalty underpayments in two new litigations are the tip of the iceberg. Read more here

THURSDAY 09 March

Weekly column: IP professionals should not fear AI, they should embrace it. Read more here

Federal Circuit fails to clear up REMS patent uncertainties in latest Orange Book ruling. Read more here

FRIDAY 10 March

The Market Makers of 2022: the top 40 countdown begins. Read more here

EPO staff endorse industry patent quality complaints. Read more here

Patent litigation finance skyrockets in past three years. Read more here

SATURDAY 11 March

Opinion: OpenSky – ending another round of IPR abuse whack-a-mole. Read more here

Unlock unlimited access to all IAM content